RxDoctor Payments Data

Mohammed Razvi, MD

Vascular & Interventional Radiology · Silver Spring, MDNPI 1750728549

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Bard Peripheral Vascular, Inc. at 24.4% of the total. 2025 is the largest year on record at $387, 2.3 times the $167 reported in 2019. That places this record below the midpoint for vascular & interventional radiology clinicians in MD, where the typical reported total is $1,962.

$1,118in general payments, 2019–2025

Across 16 payments — averaging $69.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bard Peripheral Vascular, Inc.$273
  • Teleflex LLC$195
  • Immunitybio, Inc.$135
  • Terumo Medical Corporation$116
  • Progenics Pharmaceuticals, Inc.$114
  • Sumitomo Pharma America, Inc.$112
  • plus $174 from 4 others

What the payments were for

  • Speaking & faculty fees$11210%
  • Food & beverage$1,00690%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,118 in reported general payments places this provider in the 35th percentile of 75 vascular & interventional radiology providers in Maryland.

See all vascular & interventional radiology providers in Maryland

Medicare billing

Part B allowed, 2024
$5,646,623
Medicare patients
713
Services billed
38,114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone402$2,767
Ibuprofen345$870
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim373$715
Famotidine381$565
Ciprofloxacin Hcl37$205
NitrofurantoinNitrofurantoin Macrocrystal18$166
IbuIbuprofen28$61

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Silver Spring

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →